Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News OmniAb Inc OABI

Technology Scientific & Technical Instruments
OmniAb, Inc. offers a discovery platform that provides pharmaceutical industry partners with access to diverse antibody repertoires and high-throughput screening technologies to enable the discovery of next-generation therapeutics. The OmniAb platform is the biological intelligence (BI) of transgenic animals, including OmniRat, OmniChicken, and OmniMouse, which have been genetically modified to... see more

Recent & Breaking News (NDAQ:OABI)

OmniAb to Participate in the Jefferies Global Healthcare Conference

Business Wire 17 minutes ago

OmniAb Presents High-Throughput Single B-cell Screening xPloration® Data at the 20th Annual PEGS Boston Summit

Business Wire 4 days ago

OmniAb Reports First Quarter 2024 Financial Results and Business Highlights

Business Wire 10 days ago

OmniAb to Participate in Five Investor Conferences in May

Business Wire May 1, 2024

OmniAb to Report First Quarter 2024 Financial Results on May 9

Business Wire April 22, 2024

OmniAb Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights

Business Wire March 20, 2024

OmniAb to Report Fourth Quarter 2023 Financial Results on March 20

Business Wire February 26, 2024

OmniAb to Participate in Two Investor Conferences in March

Business Wire February 20, 2024

OmniAb Presents New Scientific Data on its OmnidAb(TM) Platform at the 2023 Antibody Engineering & Therapeutics Conference

Business Wire December 14, 2023

OmniAb Highlights OmnidAb(TM) Launch and its Expanding Drug Discovery Platform at Today's Research & Technology Virtual Event

Business Wire November 9, 2023

OmniAb Reports Third Quarter 2023 Financial Results and Business Highlights

Business Wire November 9, 2023

OmniAb to Participate in Two Investor Conferences in November

Business Wire November 2, 2023

OmniAb Appoints Steve Love to its Board of Directors

Business Wire November 1, 2023

OmniAb Announces Agenda for its Research & Technology Virtual Event

Business Wire October 31, 2023

OmniAb to Hold Research & Technology Virtual Event on November 9

Business Wire October 12, 2023

OmniAb to Participate in Two Investor Conferences in September

Business Wire September 5, 2023

OmniAb Reports Second Quarter 2023 Financial Results and Business Highlights

Business Wire August 10, 2023

OmniAb Announces the Passing of Director Sunil Patel

Business Wire August 7, 2023

OmniAb to Report Second Quarter 2023 Financial Results on August 10

Business Wire July 31, 2023

OmniAb Launches OmniDeep(TM) at the PEGS Boston Conference and Expo

Business Wire May 17, 2023